D. Ciirrent Federal Funding. 
As mentioned cQsove, the major action taken by NIH, 
and other federal agencies with respect to recombinant DNA 
research was funding and not the Guidelines. The "Description" 
section must include a detailed explanation of both. It is 
importamt for Congress and the public to know the extent of 
Federal support for recombinant research todate. The DEIS is 
deficient in this respect amd shall include a description of 
outstanding NIH and other federal grants involving genetic 
recombination/ the nxamber amd amounts of such grants as well as 
their geographical locations. From such a survey, Congress and 
State governments cam evaluate the extent of research in progress 
and the need for immediate controls. This information will also 
help NIH decide policies for the funding of expensive containment 
facilities in different regions. For existing grants, the DEIS 
should explain whether compliance with the Guidelines is required 
in those contracts and whether grantees are in fact complying. 
The nature amd number of pending grant applications proposing 
recombinamt experiments should also be disclosed. 
- 6 - 
Appendix K — 86 
